CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Furberg, H.
Right arrow Articles by Newman, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Furberg, H.
Right arrow Articles by Newman, B.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 829-835, September 2002
© 2002 American Association for Cancer Research

Environmental Factors in Relation to Breast Cancer Characterized by p53 Protein Expression1

Helena Furberg2, R. C. Millikan, J. Geradts, M. D. Gammon, L. G. Dressler, C. B. Ambrosone and B. Newman

Derald H. Ruttenberg Cancer Center, Mt. Sinai School of Medicine. New York, New York 10029 [H. F., C. B. A.]; Department of Epidemiology, School of Public Health [R. C. M., M. D. G.], Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 [R. C. M., M. D. G., L. G. D.]; Department of Pathology, Roswell Park Cancer Institute, Buffalo, New York 14263 [J. G.]; and School of Public Health, Queensland University of Technology, Brisbane, QLD 4059, Australia [B. N.]

Findings from studies of cigarette smoking and low-dose ionizing radiation exposure and breast cancer are unclear. Laboratory studies indicate that both exposures can cause DNA damage, potentially increasing cancer risk if such mutations occur in growth control genes, such as p53. We examined the potential etiologic heterogeneity of breast cancer by evaluating whether associations between cigarette smoking and low-dose ionizing radiation and breast cancer differed by p53 protein expression status. Data were obtained from the Carolina Breast Cancer Study, a population-based, case-control study conducted among African-American and white women ages 20–74 years. Questionnaire data were available from 861 women with incident, primary invasive breast cancer and 790 community-based controls. p53 immunostaining was performed on tissue from 683 women with breast cancer; 46% were classified as p53+. Two separate unconditional logistic regression models were used to calculate odds ratios (ORs) for p53+ and p53- breast cancer, as compared with controls, in relation to smoking and low-dose ionizing radiation exposure. Smoking was not differentially associated with p53+ or p53- breast cancer, even when duration, dose, and passive smoking status were considered. Exposure to individual sources of radiation did not differ for p53+ and p53- breast cancers. However, ORs for combined exposure to chest X-rays and occupational radiation were higher for p53+ [OR, 2.2; 95% confidence interval (CI), 1.0–5.3] than p53- breast cancer (OR, 1.2; 95% CI, 0.5–3.4). Combined exposure to radiation from other medical sources as well as occupational exposure was also higher for p53+ (OR, 3.7; 95% CI, 0.8–16.8) than for p53- breast cancer (OR, 1.7; 95% CI, 0.3–10.5). Although preliminary, our results suggest that exposure to multiple sources of low-dose ionizing radiation may contribute to the development of p53+ breast cancer.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. C. Millikan, K. Heard, S. Winkel, E. J. Hill, K. Heard, B. Massa, L. Mayes, P. Williams, R. Holston, K. Conway, et al.
No Association Between the MDM2 -309 T/G Promoter Polymorphism and Breast Cancer in African-Americans or Whites
Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 175 - 177.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
J. L. Freudenheim, M. Bonner, S. Krishnan, C. B. Ambrosone, S. Graham, S. E. McCann, K. B. Moysich, E. Bowman, T. Nemoto, and P. G. Shields
Diet and alcohol consumption in relation to p53 mutations in breast tumors
Carcinogenesis, June 1, 2004; 25(6): 931 - 939.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
J. A. Fulop
Integrative Tumor Board: Recurrent Breast Cancer or New Primary?
Integr Cancer Ther, September 1, 2003; 2(3): 276 - 283.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2002 by the American Association for Cancer Research.